CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 13 enrolled
Drug / intervention
tDCSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01636661
NCT01636661Early Ph 1Completed
CompareCT.gov

Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis

University of Minnesota·interventional·Posted Jul 10, 2012·Updated Nov 9, 2015

In Brief

A Early Phase 1 clinical trial evaluating tDCS for Hemiparesis. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The primary objective of this proposal is to investigate the safety of use of transcranial Direct Current Stimulation (tDCS)in children with hemiparesis. The research question, "Is transcranial Direct Current Stimulation safe for use in children with congenital hemiparesis?" relates to two hypotheses: 1. tDCS will not produce a major adverse event, including seizure activity. 2. No change in paretic or nonparetic hand function or cognitive status will occur.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemiparesis
CountriesUnited States
CollaboratorsMinnesota Medical Foundation

Timeline

Early Ph 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 10, 2012
Enrollment StartJul 1, 2012
Primary CompletionAug 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.0 years ago

Interventions

tDCSdevice

transcranial direct current stimulation- non-invasive brain stimulation